File(s) under permanent embargo
Distal technologies and type 1 diabetes management
journal contribution
posted on 2018-02-01, 00:00 authored by D C Duke, S Barry, D V Wagner, Jane SpeightJane Speight, P Choudhary, M A HarrisType 1 diabetes requires intensive self-management to avoid acute and long-term health complications. In the past two decades, substantial advances in technology have enabled more effective and convenient self-management of type 1 diabetes. Although proximal technologies (eg, insulin pumps, continuous glucose monitors, closed-loop and artificial pancreas systems) have been the subject of frequent systematic and narrative reviews, distal technologies have received scant attention. Distal technologies refer to electronic systems designed to provide a service remotely and include heterogeneous systems such as telehealth, mobile health applications, game-based support, social platforms, and patient portals. In this Review, we summarise the empirical literature to provide current information about the effectiveness of available distal technologies to improve type 1 diabetes management. We also discuss privacy, ethics, and regulatory considerations, issues of global adoption, knowledge gaps in distal technology, and recommendations for future directions.
History
Journal
Lancet diabetes and endocrinologyVolume
6Issue
2Pagination
143 - 156Publisher
ElsevierLocation
Amsterdam, The NetherlandsPublisher DOI
ISSN
2213-8587eISSN
2213-8595Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2018, ElsevierUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC